Novo Nordisk’s India Insulin Push and Aggressive Buyback Counterbalance a Pipeline Jolt
Novo Nordisk ended the week at €43.32, a 1.29% gain on Friday that masked a slightly negative weekly…
Novo Nordisk’s Pill Lands in the UK With 70,000 Waiting as Medicare Push Opens a New US Front
Novo Nordisk is firing on two growth cylinders. The Danish pharma giant has just launched its oral Wegovy…
Novo Nordisk’s Wegovy Broadens Its Reach: UK MASH Nod, Medicare Push, and a Billion-Dollar Parent
Novo Nordisk’s bestselling GLP-1 drug is no longer tethered solely to obesity. The Danish pharma giant has locked…
European Lithium’s Greenland Rare Earth Bonanza Drives Merger Push and 177% Stock Rally
The stars are aligning for European Lithium as its planned takeover by Critical Metals Corp. draws closer, powered…
Novo Nordisk’s Pipeline and China Push Chip Away at a 41% Stock Decline
Two narratives are competing for Novo Nordisk’s share price. One points to a stock that is trading at…
Sabotage on Berlin Power Grid Accelerates Germany’s Push for National Reserve and €10 Billion Prot
The timing of a new planning handbook for emergency power supply, set for release in September by the…
Novo Nordisk’s Pill Push Gains Ground as Profit Outlook Fades
The Wegovy tablet has become the fastest-selling obesity drug in US history, racking up more than three million…
Novo Nordisk’s Pipeline Push: From Novel Injectables to Combination Trials as Shares Languish at His
Novo, Nordisks
05.06.2026 – 08:24:16 | boerse-global.de
Novo Nordisk shares trade at…
Coalition of major European Union countries push for tougher China policy ahead of Brussels debate
Agencies Brussels A coalition of major EU member states is pushing Brussels towards a much tougher trade regime…
Novo Nordisk’s Distribution Push Collides With Margin Squeeze as Pipeline Nears Inflection
Oral Wegovy scripts soar, but US pricing pressure and India generics erode margins. Stock down 35% in a…
Novo Nordisk’s High-Dose Shot and Amazon Push Provide Lift, Yet Stock Sags on Generics and FDA Rev
Despite strong weight-loss data and an Amazon Pharmacy deal, Novo Nordisk shares slump on patent cliff fears, FDA…
Novo Nordisk Abandons Rare-Disease Factory for Warehouse Push as Canada Opens Door to Semaglutid Gen
Dr. Reddy’s launches generic semaglutide in Canada, breaching Novo Nordisk’s exclusivity. Novo shifts $1.33B plant to warehouse, as…